Mapping the DNA Damaging Effects of Polypyridyl Copper Complexes with DNA Electrochemical Biosensors

Anna Banasiak1, Nicolò Zuin Fantoni2,3, Andrew Kellett3,4

  • 1Applied Electrochemistry Group, FOCAS Institute, Technological University Dublin, Camden Row, Dublin 8, D08 CKP1 Dublin, Ireland.

Insights

New copper complexes featuring tris-2-pyridylmethylamine (TPMA) ligands show significant potential as anticancer agents. These TPMA-based compounds demonstrate enhanced DNA cleavage activity, offering a promising avenue for drug discovery.

Area of Science:

  • Coordination Chemistry
  • Biophysical Chemistry
  • Materials Science

Background:

  • Copper complexes are investigated for their ability to induce oxidative DNA damage, a mechanism relevant to anticancer drug development.
  • A DNA electrochemical biosensor was previously developed to quantify DNA cleavage activity of copper complexes like [Cu(phen)2]2+.
  • Broader compatibility of the biosensor with diverse copper complexes is needed for drug discovery applications.

Purpose of the Study:

  • To evaluate the DNA binding and quantitative cleavage activity of the [Cu(TPMA)(N,N)]2+ class of copper complexes using a DNA electrochemical biosensor.
  • To assess the compatibility of the biosensor with new, biologically relevant copper complexes.
  • To explore the potential of TPMA-based copper complexes as anticancer agents.

Main Methods:

  • Synthesis and characterization of [Cu(TPMA)(N,N)]2+ complexes, where TPMA is tris-2-pyridylmethylamine and N,N is a bidentate planar phenanthrene ligand.
  • Utilized a DNA electrochemical biosensor to quantify DNA cleavage activity.
  • Investigated DNA interaction modes, including intercalation and electrostatic attraction.

Main Results:

  • All synthesized complexes exhibited electroactivity and interacted with DNA via partial intercalation and electrostatic attraction.
  • [Cu(TPMA)(phen)]2+ and [Cu(TPMA)(DPQ)]2+ showed significant DNA cleavage (39% and 48%, respectively), while [Cu(TPMA)(bipy)]2+ and [Cu(TPMA)(PD)]2+ exhibited moderate activity (ca. 26%).
  • The presence of the TPMA ligand significantly enhanced chemical nuclease activity compared to [Cu(phen)2]2+.

Conclusions:

  • The DNA electrochemical biosensor is compatible with copper(II) polypyridyl complexes.
  • TPMA-based copper complexes are promising DNA-damaging agents with tunable activity modulated by ancillary ligands.
  • These findings support the development of TPMA complexes as potential anticancer therapeutics.